Quick Answer Aldeyra Therapeutics, Inc. reported Long-Term Debt of $0.00 for fiscal year 2025. Aldeyra Therapeutics, Inc. Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $0.00 -100.0% 2024 $15.00M — 2023 $0.00 -100.0% 2022 $14.92M -3.7% 2021 $15.50M +35.6% 2020 $11.43M -21.3% 2019 $14.53M +1090.6% 2017 $1.22M -1.5% 2016 $1.24M +2.3% … Read more
Quick Answer Aldeyra Therapeutics, Inc. reported Cash and Equivalents of $47.36 million for fiscal year 2018. Aldeyra Therapeutics, Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2018 $47.36M +136.5% 2017 $20.02M +66.7% 2016 $12.02M -18.0% 2015 $14.65M +71.8% 2014 $8.53M +161.4% 2013 $3.26M +166.6% 2012 $1.22M — Quarterly Cash … Read more
Quick Answer Aldeyra Therapeutics, Inc. reported Total Assets of $72.06 million for fiscal year 2025. Aldeyra Therapeutics, Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $72.06M -31.1% 2024 $104.61M -29.5% 2023 $148.33M -18.2% 2022 $181.29M -22.2% 2021 $233.14M +179.7% 2020 $83.35M +10.4% 2019 $75.52M -20.6% 2018 $95.09M +115.3% 2017 $44.17M … Read more
Quick Answer Aldeyra Therapeutics, Inc. reported Net Income of -$33.85 million for fiscal year 2025. Aldeyra Therapeutics, Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$33.85M +39.4% 2024 -$55.85M -48.8% 2023 -$37.54M +39.5% 2022 -$62.02M -7.4% 2021 -$57.78M -53.8% 2020 -$37.55M +38.3% 2019 -$60.83M -56.4% 2018 -$38.89M -74.1% 2017 -$22.34M … Read more
Quick Answer Aldeyra Therapeutics, Inc. reported Diluted EPS of $0.56 per share (loss) for fiscal year 2025. Aldeyra Therapeutics, Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$0.56 +40.4% 2024 -$0.94 -46.9% 2023 -$0.64 +39.6% 2022 -$1.06 +0.9% 2021 -$1.07 +23.6% 2015 -$1.40 +54.7% 2014 -$3.09 +82.5% 2013 -$17.61 — … Read more
Quick Answer Aldeyra Therapeutics, Inc. reported Net Income of -$33.85 million for fiscal year 2025. Aldeyra Therapeutics, Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Net Income -$33.85M+39.4% -$55.85M-48.8% -$37.54M+39.5% -$62.02M-7.4% -$57.78M-53.8% -$37.55M+38.3% Diluted EPS -$0.56+40.4% -$0.94-46.9% -$0.64+39.6% -$1.06+0.9% -$1.07 — Total Assets $72.06M-31.1% $104.61M-29.5% $148.33M-18.2% $181.29M-22.2% $233.14M+179.7% $83.35M+10.4% Cash … Read more
Quick Answer APPlife Digital Solutions Inc reported Shares Outstanding of 2.00 billion shares for fiscal year 2025. APPlife Digital Solutions Inc Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 2.00B +1228.5% 2024 150.54M +0.0% 2023 150.54M +1.3% 2022 148.54M +9.6% 2021 135.52M +6.7% 2020 127.04M +6.7% 2019 119.06M +590.6% 2018 17.24M … Read more
Quick Answer APPlife Digital Solutions Inc reported Operating Income of -$201.9 thousand for fiscal year 2025. APPlife Digital Solutions Inc Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$201.9K +95.9% 2024 -$4.96M -58.3% 2023 -$3.13M -4.0% 2022 -$3.01M +19.0% 2021 -$3.72M +1.5% 2020 -$3.77M -155.5% 2019 -$1.48M — Quarterly Operating Income … Read more
Quick Answer APPlife Digital Solutions Inc reported Gross Profit of $44.2 thousand for fiscal year 2025. APPlife Digital Solutions Inc Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $44.2K +175.7% 2024 -$58.4K -4233.6% 2023 -$1.3K -159.8% 2022 $2.3K +77.7% 2021 $1.3K +11.0% 2020 $1.1K — 2019 $0.00 — Quarterly Gross Profit … Read more
Quick Answer APPlife Digital Solutions Inc reported Stockholders Equity of -$811.8 thousand for fiscal year 2025. APPlife Digital Solutions Inc Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 -$811.8K — 2024 $0.00 +100.0% 2023 -$1.44M -75.4% 2022 -$818.9K -84.0% 2021 -$445.0K +0.0% 2020 -$445.0K -275.5% 2019 $253.6K +389.5% 2018 -$87.6K — … Read more